Stock Scorecard
Stock Summary for Vapotherm Inc (VAPO) - $1.26 as of 4/23/2024 2:01:57 PM EST
Total Score
10 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for VAPO
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for VAPO
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for VAPO
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for VAPO
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for VAPO
Financial Details for VAPO
Company Overview |
|
---|---|
Ticker | VAPO |
Company Name | Vapotherm Inc |
Country | USA |
Description | Vapotherm, Inc., a medical technology company, is focused on the development and commercialization of proprietary high-speed therapy products that are used to treat patients of various ages with respiratory distress in the United States and internationally. The company is headquartered in Exeter, New Hampshire. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/1/2024 |
Stock Price History |
|
Last Day Price | 1.26 |
Last Day Price Updated | 4/23/2024 2:01:57 PM EST |
Last Day Volume | 79 |
Average Daily Volume | 7,672 |
52-Week High | 7.44 |
52-Week Low | 0.75 |
Last Price to 52 Week Low | 68.00% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 47.46 |
Sector PE | 60.54 |
5-Year Average PE | -42.50 |
Free Cash Flow Ratio | 0.80 |
Industry Free Cash Flow Ratio | 61.03 |
Sector Free Cash Flow Ratio | 30.19 |
Current Ratio Most Recent Quarter | 2.43 |
Total Cash Per Share | 1.57 |
Book Value Per Share Most Recent Quarter | -8.97 |
Price to Book Ratio | 7.11 |
Industry Price to Book Ratio | 5.21 |
Sector Price to Book Ratio | 22.08 |
Price to Sales Ratio Twelve Trailing Months | 0.14 |
Industry Price to Sales Ratio Twelve Trailing Months | 14.23 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
Total Shares Outstanding | 6,193,800 |
Market Capitalization | 7,804,188 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 48.62% |
Reported EPS 12 Trailing Months | -9.64 |
Reported EPS Past Year | -3.12 |
Reported EPS Prior Year | -3.47 |
Net Income Twelve Trailing Months | -58,193,000 |
Net Income Past Year | -58,193,000 |
Net Income Prior Year | -113,259,000 |
Quarterly Revenue Growth YOY | 5.70% |
5-Year Revenue Growth | 9.31% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 9,725,000 |
Total Cash Past Year | 9,725,000 |
Total Cash Prior Year | 15,738,000 |
Net Cash Position Most Recent Quarter | -95,034,000 |
Net Cash Position Past Year | -95,034,000 |
Long Term Debt Past Year | 104,759,000 |
Long Term Debt Prior Year | 93,994,000 |
Total Debt Most Recent Quarter | 104,759,000 |
Equity to Debt Ratio Past Year | -1.12 |
Equity to Debt Ratio Most Recent Quarter | -1.12 |
Total Stockholder Equity Past Year | -55,334,000 |
Total Stockholder Equity Prior Year | -28,190,000 |
Total Stockholder Equity Most Recent Quarter | -55,334,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | False |
Liquidity Rating | None |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.04 |
MACD Signal | 0.06 |
20-Day Bollinger Lower Band | 0.67 |
20-Day Bollinger Middle Band | 1.12 |
20-Day Bollinger Upper Band | 1.56 |
Beta | -1.10 |
RSI | 45.32 |
50-Day SMA | 2.49 |
200-Day SMA | 99.26 |
System |
|
Modified | 4/23/2024 2:02:00 PM EST |